Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iacopo Chiodini

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Endocrine|February 15, 2021
Update on primary bilateral macronodular adrenal hyperplasia (PBMAH)Lucas Bouys, Iacopo Chiodini, Wiebke Arlt, et al.
European Journal of Endocrinology|January 17, 2012
PTHrP-associated hypercalcemia of pregnancy resolved after delivery: a case reportCristina Eller-Vainicher, Manuela Wally Ossola, Paolo Beck-Peccoz, et al.
Journal of Endocrinological Investigation|August 26, 2025
Lowering the dexamethasone suppression test cut-off: is it time yet?Vittoria Favero, Cristina Eller-Vainicher, Valentina Morelli, et al.
Expert Review of Endocrinology & Metabolism|June 26, 2020
Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosisIacopo Chiodini, Alberto Falchetti, Daniela Merlotti, et al.
Frontiers in Medicine|February 10, 2022
Case Report: Unusual Presentations of Loss-of-Function Mutations of the Calcium-Sensing ReceptorSerena Palmieri, Giorgia Grassi, Vito Guarnieri, et al.
European Journal of Endocrinology|July 7, 2021
Bisphosphonates after denosumab withdrawal reduce the vertebral fractures incidenceGiorgia Grassi, Iacopo Chiodini, Serena Palmieri, et al.
Expert Opinion on Therapeutic Targets|February 14, 2020
Emerging therapeutic targets for osteoporosisLuigi Gennari, Daniela Merlotti, Alberto Falchetti, et al.
Journal of Clinical Medicine|September 27, 2025
Sequential Treatment for Osteoporosis After Teriparatide: A Real-Life Long-Term Comparison Between Zoledronic Acid and DenosumabAlberto Ghielmetti, Giorgia Grassi, Marta Zampogna, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 8, 2023
Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing's DiseaseAndreea Liliana Serban, Benedetta Zampetti, Andrea Saladino, et al.
Frontiers in Endocrinology|May 7, 2026
Endocrine-related osteoporosis: the state of the artIacopo Chiodini, Agostino Gaudio, Luigi Gennari, et al.
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Endocrine|February 15, 2021
Update on primary bilateral macronodular adrenal hyperplasia (PBMAH)Lucas Bouys, Iacopo Chiodini, Wiebke Arlt, et al.
European Journal of Endocrinology|January 17, 2012
PTHrP-associated hypercalcemia of pregnancy resolved after delivery: a case reportCristina Eller-Vainicher, Manuela Wally Ossola, Paolo Beck-Peccoz, et al.
Journal of Endocrinological Investigation|August 26, 2025
Lowering the dexamethasone suppression test cut-off: is it time yet?Vittoria Favero, Cristina Eller-Vainicher, Valentina Morelli, et al.
Expert Review of Endocrinology & Metabolism|June 26, 2020
Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosisIacopo Chiodini, Alberto Falchetti, Daniela Merlotti, et al.
Frontiers in Medicine|February 10, 2022
Case Report: Unusual Presentations of Loss-of-Function Mutations of the Calcium-Sensing ReceptorSerena Palmieri, Giorgia Grassi, Vito Guarnieri, et al.
European Journal of Endocrinology|July 7, 2021
Bisphosphonates after denosumab withdrawal reduce the vertebral fractures incidenceGiorgia Grassi, Iacopo Chiodini, Serena Palmieri, et al.
Expert Opinion on Therapeutic Targets|February 14, 2020
Emerging therapeutic targets for osteoporosisLuigi Gennari, Daniela Merlotti, Alberto Falchetti, et al.
Journal of Clinical Medicine|September 27, 2025
Sequential Treatment for Osteoporosis After Teriparatide: A Real-Life Long-Term Comparison Between Zoledronic Acid and DenosumabAlberto Ghielmetti, Giorgia Grassi, Marta Zampogna, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 8, 2023
Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing's DiseaseAndreea Liliana Serban, Benedetta Zampetti, Andrea Saladino, et al.
Frontiers in Endocrinology|May 7, 2026
Endocrine-related osteoporosis: the state of the artIacopo Chiodini, Agostino Gaudio, Luigi Gennari, et al.
Pageof 14